BIOMAT Database Logo BIOMAT Database Logo

Dexamethasone suppression test and treatment response. 1984

M J Gitlin, and H Gwirtsman, and L Fairbanks, and H A Sternbach, and P I Cedars, and R H Gerner

The dexamethasone suppression test (DST) is frequently used to predict response to antidepressant therapy or to noradrenergic vs. serotonergic antidepressants. In a study of 173 inpatients and outpatients, the DST was not found to be predictive of response to antidepressant treatment for all depressed patients or of treatment response in a subgroup of melancholic patients (N = 86). Response of DST suppressors and nonsuppressors to antidepressants stratified by neurotransmitter specificity was not found to differ.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M J Gitlin, and H Gwirtsman, and L Fairbanks, and H A Sternbach, and P I Cedars, and R H Gerner
Dexamethasone suppression test and response to MAOI treatment.
March 1989, The Journal of clinical psychiatry,
M J Gitlin, and H Gwirtsman, and L Fairbanks, and H A Sternbach, and P I Cedars, and R H Gerner
Dexamethasone suppression test as a predictor of drug treatment response.
January 1984, Progress in neuro-psychopharmacology & biological psychiatry,
M J Gitlin, and H Gwirtsman, and L Fairbanks, and H A Sternbach, and P I Cedars, and R H Gerner
The dexamethasone suppression test and response to somatic treatment: a review.
January 1986, The Journal of clinical psychiatry,
M J Gitlin, and H Gwirtsman, and L Fairbanks, and H A Sternbach, and P I Cedars, and R H Gerner
The dexamethasone suppression test and response to placebo.
October 1986, Journal of clinical psychopharmacology,
M J Gitlin, and H Gwirtsman, and L Fairbanks, and H A Sternbach, and P I Cedars, and R H Gerner
[ACTH response in the dexamethasone suppression test].
January 1982, Medizinische Klinik (Klinik-Ausg.),
M J Gitlin, and H Gwirtsman, and L Fairbanks, and H A Sternbach, and P I Cedars, and R H Gerner
Dexamethasone suppression test: different categories of response.
August 1984, The British journal of psychiatry : the journal of mental science,
M J Gitlin, and H Gwirtsman, and L Fairbanks, and H A Sternbach, and P I Cedars, and R H Gerner
Dexamethasone suppression test.
December 1982, Journal of clinical psychopharmacology,
M J Gitlin, and H Gwirtsman, and L Fairbanks, and H A Sternbach, and P I Cedars, and R H Gerner
Dexamethasone suppression test.
July 1986, The British journal of psychiatry : the journal of mental science,
M J Gitlin, and H Gwirtsman, and L Fairbanks, and H A Sternbach, and P I Cedars, and R H Gerner
[Dexamethasone suppression test].
June 1979, Nihon rinsho. Japanese journal of clinical medicine,
M J Gitlin, and H Gwirtsman, and L Fairbanks, and H A Sternbach, and P I Cedars, and R H Gerner
Dexamethasone suppression test.
January 1988, Acta psychiatrica Scandinavica. Supplementum,
Copied contents to your clipboard!